Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hyperparathyroidism; Secondary, Renal”

211 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 211 results

Testing effectiveness (Phase 2)Looking for participantsNCT06906874
What this trial is testing

Activated Charcoal Use in Chronic Kidney Disease Patients

Who this might be right for
End Stage Renal Disease (ESRD)CKD 5D, HemodialysisCKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder
Mansoura University 40
Post-approval studies (Phase 4)UnknownNCT05720273
What this trial is testing

Neutrophil Gelatinase-associated Lipocalin VS Vascular Calcification in Maintenance Hemodialysis Patients

Who this might be right for
Chronic Kidney Disease-Mineral and Bone Disorder
Xiaoyan Jia 80
Post-approval studies (Phase 4)Study completedNCT01100723
What this trial is testing

Trial to Optimize Mineral Outcomes in Dialysis Patients

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease
University of Colorado, Denver 92
Post-approval studies (Phase 4)Study completedNCT03182699
What this trial is testing

Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease Requiring Chronic DialysisLeft Ventricular Hypertrophy
Rainer Oberbauer 62
Testing effectiveness (Phase 2)Study completedNCT01254565
What this trial is testing

Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism

Who this might be right for
Secondary Hyperparathyroidism
KAI Pharmaceuticals 87
Large-scale testing (Phase 3)Ended earlyNCT05543928
What this trial is testing

Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism

Who this might be right for
Chronic Kidney Disease stage3Chronic Kidney Disease stage4Vitamin d Deficiency+1 more
OPKO Health, Inc. 2
Not applicableLooking for participantsNCT05880914
What this trial is testing

Precision Medicine Approaches to Renal Osteodystrophy

Who this might be right for
Renal OsteodystrophyChronic Kidney DiseasesCKD-MBD+2 more
Thomas Nickolas 40
Large-scale testing (Phase 3)UnknownNCT00752401
What this trial is testing

Vitamin D3 Substitution in Vitamin D Deficient Kidney Transplant Recipients

Who this might be right for
Kidney TransplantationVitamin D DeficiencyRenal Osteodystrophy
Medical University of Vienna 200
Not applicableLooking for participantsNCT03716128
What this trial is testing

Diagnosis of Renal Osteodystrophy in Patients With Reduced Renal Function

Who this might be right for
Renal Osteodystrophy
Ditte Hansen 40
Post-approval studies (Phase 4)Study completedNCT01939977
What this trial is testing

Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation.

Who this might be right for
Secondary Hyperparathyroidism Due to Renal Causes
Fundación Senefro 148
Not applicableUnknownNCT05439980
What this trial is testing

Improving Phosphate Control in Children With CKD

Who this might be right for
Chronic Kidney DiseasesHyperphosphatemiaPediatric Kidney Disease+2 more
Great Ormond Street Hospital for Children NHS Foundation Trust 100
Not applicableStudy completedNCT00781417
What this trial is testing

Prevention of Secondary Hyperparathyroidism With Vitamin D in Stage II/III Chronic Kidney Disease

Who this might be right for
Kidney Disease
Atlanta VA Medical Center 48
Not applicableStudy completedNCT00427037
What this trial is testing

Cholecalciferol (Vitamin D3) Therapy in Chronic Kidney Disease (CKD) Subjects

Who this might be right for
Chronic Kidney DiseaseVitamin D Deficiency
Atlanta VA Medical Center 34
Post-approval studies (Phase 4)Study completedNCT00431496
What this trial is testing

Cinacalcet to Improve Achievement of National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With End Stage Renal Disease (ESRD)

Who this might be right for
AnemiaSecondary Hyperparathyroidism
Amgen 71
Not applicableStudy completedNCT01073462
What this trial is testing

Study to Evaluate the Effect of Intravenous (IV) Paricalcitol (Zemplar) on Cardiac Morbidity in Patients With Chronic Kidney Disease (CKD) Stage 5 Over 2 Years

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease Stage VCardiac Morbidity
AbbVie (prior sponsor, Abbott) 67
Large-scale testing (Phase 3)Study completedNCT01788046
What this trial is testing

Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

Who this might be right for
Hyperparathyroidism, Secondary
Amgen 515
Large-scale testing (Phase 3)Study completedNCT00527267
What this trial is testing

Safety and Efficacy Study of AMG 073 in Hemodialysis Subjects

Who this might be right for
Hyperparathyroidism
Amgen 320
Post-approval studies (Phase 4)Study completedNCT00463021
What this trial is testing

Determine Dosing of Hectorol® Capsules When Converting From Zemplar® Injection

Who this might be right for
Secondary Hyperparathyroidism
Genzyme, a Sanofi Company 36
Early research (Phase 1)Study completedNCT00888069
What this trial is testing

Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects

Who this might be right for
Chronic Kidney DiseaseSecondary HyperparathyroidismChronic Renal Insufficiency+1 more
OPKO IP Holdings II, Inc. 28
Not applicableStudy completedNCT00189501
What this trial is testing

A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)

Who this might be right for
Nephrology
Amgen 1,000
Load More Results